Cadbel Pharmaceuticals Private Limited
Medical & pharmaceutical products business, incorporated in 2016, based in Karnataka.
2016 | Bangaluru, Karnataka (India) | Active
Cadbel Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.45 M
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 2.40 M
About Cadbel Pharmaceuticals
Cadbel Pharmaceuticals Private Limited (CPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 04 July 2016 (Eight years and seven months 26 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.45 M.
The company currently has active open charges totaling ₹2.40 M.
Basavaraju Kumar, Mudugare Kavya, Suvarna, and One other member serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U36990KA2016PTC094674
- Company No.
094674
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2016
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Pharma
Who are the key members and board of directors at Cadbel Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shreyas Nagendrababu  | Additional Director | 16-Jan-2019 | Current |
| Basavaraju Kumar | Director | 04-Jul-2016 | Current |
| Mudugare Kavya | Director | 04-Jul-2016 | Current |
| Suvarna | Additional Director | 16-Jan-2019 | Current |
Financial Performance of Cadbel Pharmaceuticals.
Cadbel Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cadbel Pharmaceuticals?
In 2017, Cadbel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹2.40 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2017 | State Bank Of India | ₹2.40 M | Open |
How Many Employees Work at Cadbel Pharmaceuticals?
Unlock and access historical data on people associated with Cadbel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cadbel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cadbel Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.